tiprankstipranks
Advertisement
Advertisement

ABBV Stock Latest News

AbbVie Advances New Autoimmune Drug ABBV-519 Into First-in-Human Trial, Signaling Next Wave in Immunology
Company AnnouncementsAbbVie Advances New Autoimmune Drug ABBV-519 Into First-in-Human Trial, Signaling Next Wave in Immunology
22h ago
ABBV
AbbVie announces EC authorizes expanded label for Venclyxto
PremiumThe Fly
AbbVie announces EC authorizes expanded label for Venclyxto
1d ago
ABBV
AbbVie Expands Early Pipeline With New First-in-Human Study for ABBV-1451
PremiumCompany Announcements
AbbVie Expands Early Pipeline With New First-in-Human Study for ABBV-1451
2d ago
ABBV
AbbVie announces FDA approval of DECNUPAZ
PremiumThe Fly
AbbVie announces FDA approval of DECNUPAZ
3d ago
ABBV
FDA approves AbbVie’s Decnupaz for blastic plasmacytoid dendritic cell neoplasm
PremiumThe Fly
FDA approves AbbVie’s Decnupaz for blastic plasmacytoid dendritic cell neoplasm
3d ago
ABBV
AbbVie reports positive CHMP opinion for Maviret
PremiumThe FlyAbbVie reports positive CHMP opinion for Maviret
8d ago
ABBV
AbbVie’s Allergan Aesthetics receives positive CHMP opinion for Boey
Premium
The Fly
AbbVie’s Allergan Aesthetics receives positive CHMP opinion for Boey
9d ago
ABBV
AbbVie’s NAAVIGATE Trial Targets One-Time Gene Therapy for Diabetic Retinopathy
Premium
Company Announcements
AbbVie’s NAAVIGATE Trial Targets One-Time Gene Therapy for Diabetic Retinopathy
10d ago
ABBV
AbbVie Earnings Call Highlights Growth Amid Transition
PremiumCompany Announcements
AbbVie Earnings Call Highlights Growth Amid Transition
10d ago
ABBV
AbbVie price target lowered to $235 from $236 at Evercore ISI
PremiumThe Fly
AbbVie price target lowered to $235 from $236 at Evercore ISI
15d ago
ABBV
3 ‘Strong Buy’ Dividend Aristocrat Stocks with 100%+ Payout Ratios, 5/14/26
PremiumMarket News
3 ‘Strong Buy’ Dividend Aristocrat Stocks with 100%+ Payout Ratios, 5/14/26
16d ago
ABT
NEE
AbbVie Quietly Expands Its Obesity Bet With New ABBV-295 Trial
PremiumCompany Announcements
AbbVie Quietly Expands Its Obesity Bet With New ABBV-295 Trial
16d ago
ABBV
AbbVie’s ABBV-951 Parkinson’s Extension Study Completes, Setting Up Key Long-Term Safety Readout
PremiumCompany AnnouncementsAbbVie’s ABBV-951 Parkinson’s Extension Study Completes, Setting Up Key Long-Term Safety Readout
16d ago
ABBV
AbbVie price target raised to $298 from $294 at Piper Sandler
Premium
The Fly
AbbVie price target raised to $298 from $294 at Piper Sandler
16d ago
ABBV
AbbVie Shareholders Back Directors, Maintain Governance Structure
Premium
Company Announcements
AbbVie Shareholders Back Directors, Maintain Governance Structure
18d ago
8K
ABBV
AbbVie’s New Drug Milestone Fuels Hype Despite Insider Selling
PremiumWeekend Updates
AbbVie’s New Drug Milestone Fuels Hype Despite Insider Selling
21d ago
ABBV
Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
PremiumMarket News
Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
21d ago
BLK
IBB
AbbVie Completes Early Safety Study for ABBV-142, Nudging Pipeline Hopes Higher
PremiumCompany Announcements
AbbVie Completes Early Safety Study for ABBV-142, Nudging Pipeline Hopes Higher
23d ago
ABBV
AbbVie presented new data across its gastroenterology portfolio at the 2026 DDW
PremiumThe Fly
AbbVie presented new data across its gastroenterology portfolio at the 2026 DDW
25d ago
ABBV
AbbVie price target raised to $236 from $232 at Evercore ISI
PremiumThe FlyAbbVie price target raised to $236 from $232 at Evercore ISI
26d ago
ABBV
3 Top Dividend Aristocrat Stocks That Could Hand Investors 20%+ Returns
Premium
Market News
3 Top Dividend Aristocrat Stocks That Could Hand Investors 20%+ Returns
29d ago
IBM
MCD
AbbVie Stock Forecast: Trending Strong Buy Among Analysts
Premium
Analysts
AbbVie Stock Forecast: Trending Strong Buy Among Analysts
29d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >